# Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction

> **NCT03359863** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 10 (actual)

## Conditions studied

- Restrictive Chronic Lung Allograft Dysfunction
- Lung Transplant Rejection

## Interventions

- **DRUG:** Pirfenidone

## Key facts

- **NCT ID:** NCT03359863
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-07
- **Primary completion:** 2021-10-28
- **Final completion:** 2021-10-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359863, "Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03359863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*